Trial Profile
A prospective, observational, multicenter study evaluating adherence to and acceptance of once daily tacrolimus (Advagraf ) initiation in kidney and liver transplant recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Transplant rejection
- Focus Therapeutic Use
- Acronyms OSIRIS
- 24 Oct 2016 New trial record
- 01 Oct 2016 Results published in the Transplantation